Key Clinical Trials in BPH

From the contents: Phenoxybenzamine - treatment of benign prostatic obstruction.- Terazosin - management of the symptoms associated with BPH.- Terazosin - long-term treatment of the symptomatic BPH.- The utility of Finasteride - long-term management of symptomatic BPH.- Finasteride efficacy over 5 years.- Finasteride impact on acute urinary retention and surgical intervention over 4 years.- Leuprolide - treatment of BPH.- Alfuzosin - long-term medical management of BPH.- Alfuzosin - a long-term follow-up of patients in a community based setting.- Doxazosin in normotensive and controlled hypertensive patients.- Doxazosin, in normotensive patients and in patients with concomitant hypertension.- Doxazosin in hypertensive and normotensive patients.- Alfuzosin.- Doxazosin.- Comparison of Terazosin, Finasteride and both in combination, for the treatment of BPH.- Phytotherapy compared to Finasteride .- Transurethral surgery versus watchful waiting for the treatment of moderate symptoms of BPH.- The AUA Symptom Index.- Placebo therapy .- Analysis of the 'placebo effect'.